The round was led by Ottobock, a global leader in the fields of prosthetics, orthotics, and exoskeleton technology. The round includes participation from existing investors, including Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, and Risk and Return, as well as new investors Actual VC, METIS Innovative, e1 Ventures, Jumpspace, MainSheet Ventures, and Brown Advisory.

Phantom Neuro is a neurotechnology company developing a minimally invasive interface that enables intuitive control of prosthetic limbs and robotic exoskeletons. Its core platform, Phantom X, is designed to restore natural movement and functionality for amputees and individuals with mobility impairments, allowing robotic devices to function as seamless extensions of the human body. Originally developed at the Johns Hopkins University School of Medicine, Phantom Neuro has received funding support from investors including Blackrock Neurotech, Breakout Ventures, Draper Associates, LionBird Ventures, and Time BioVentures.